BioVersys AG Market Cap

BioVersys AG has a market cap or net worth of 172.52 million as of April 28, 2026. Its market cap has decreased by -13.38% in one year.

Market Cap

172.52M

Enterprise Value

111.74M

Revenue

3.18M

Ranking

n/a

PE Ratio

n/a

Stock Price

29.90

Market Cap Chart

Since February 6, 2025, BioVersys AG's market cap has decreased from 207.92M to 172.52M, a decrease of -17.03%. That is a compound annual growth rate of -14.20%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	172.52M	20.90%
Dec 30, 2025	142.69M	-31.37%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Xlife Sciences AG	122.85M
Molecular Partners AG	122.34M
Santhera Pharmaceuticals Holding AG	235.92M
Newron Pharmaceuticals	324.15M
MindMaze Therapeutics Holding	45.93M
Basilea Pharmaceutica AG	651.45M
Idorsia	945.16M
EvoNext Holdings	7.07M

Market Cap Rankings